Oxalyl chloride → methyl 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-(chlorocarbonyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoate

HRID 2405473Notes

Reaction equation

HRID 2405473 reaction equation
[CH3:1][O:2][C:3]([C:5]1[CH:10]=[CH:9][C:8]([C:11]2[C:12]([CH3:42])([CH3:41])[C@H:13]3[C@:26]([CH3:29])([CH2:27][CH:28]=2)[C@@H:25]2[C@:16]([CH3:40])([C@@:17]4([CH3:39])[CH:22]([CH2:23][CH2:24]2)[C@H:21]2[C@H:30]([C:33]([CH3:35])=[CH2:34])[CH2:31][CH2:32][C@:20]2([C:36]([OH:38])=O)[CH2:19][CH2:18]4)[CH2:15][CH2:14]3)=[CH:7][CH:6]=1)=[O:4].C(Cl)(=O)C([Cl:46])=O>ClCCl>[Cl:46][C:36]([C@:20]12[CH2:32][CH2:31][C@@H:30]([C:33]([CH3:35])=[CH2:34])[C@@H:21]1[C@@H:22]1[C@@:17]([CH3:39])([CH2:18][CH2:19]2)[C@@:16]2([CH3:40])[C@@H:25]([C@:26]3([CH3:29])[C@@H:13]([CH2:14][CH2:15]2)[C:12]([CH3:41])([CH3:42])[C:11]([C:8]2[CH:9]=[CH:10][C:5]([C:3]([O:2][CH3:1])=[O:4])=[CH:6][CH:7]=2)=[CH:28][CH2:27]3)[CH2:24][CH2:23]1)=[O:38]

Participants

4

Reactant 2

HCID 65578Oxalyl chlorideHCID 67774368HCID 67774368, compound

Product 1

HCID 86666171methyl 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-(chlorocarbonyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoate

Reagents, catalysts & solvents 1

HCID 6344DichloromethaneSolvent

Procedure

To a flask containing (1R,3aS,5aR,5bR,7aR,11aS,11bR,13bR)-9-(4-(methoxycarbonyl)phenyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid (0.1-4.2 mmol scale) was added oxalyl chloride (2M in dichloromethane) (10-50 equiv.). The solution was stirred at rt for 2-5 h and was stripped of solvent. The residue was dissolved in dichloromethane and concentrated two additional times, then was used with no additional purification in the next step. 1H NMR (500 MHz, CHLOROFORM-d) δ ppm 7.92 (d, J=8.55 Hz, 2H), 7.19 (d, J=8.24 Hz, 2H), 5.26-5.30 (m, 1H), 4.73 (d, J=1.53 Hz, 1H), 4.62-4.64 (m, 1H), 3.90 (s, 3H), 2.81 (td, J=11.14, 4.58 Hz, 1H), 2.47 (ddd, J=13.58, 3.20, 3.05 Hz, 1H), 2.19-2.28 (m, 2H), 2.10 (dd, J=17.09, 6.41 Hz, 1H), 1.85-1.99 (m, 1H), 1.68 (s, 3H), 1.00 (s, 6H), 0.98 (s, 3H), 0.92 (s, 3H), 0.92 (s, 3H), 0.84-1.83 (m, 17H). 13C NMR (126 MHz, CHLOROFORM-d) δ ppm 177.49, 167.35, 149.46, 148.81, 146.39, 130.17 (s, 2C), 128.61 (s, 2C), 128.03, 124.12, 110.40, 68.00, 52.99, 52.11, 49.78, 49.67, 46.11, 42.54, 41.86, 40.70, 38.00, 37.60, 36.39, 36.31, 33.64, 32.3, 29.98, 29.72, 29.54, 25.60, 21.37, 21.13, 19.86, 19.48, 16.59, 15.71, 14.89.

Workup

  1. concentrationconcentrated two additional times
  2. customwas used with no additional purification in the next step

Sources & evidence

ORD record
ord-fdf8690e4db040deb6502f4d3c9f6958
Source dataset
uspto-grants-2014_08
Patent number
US08802661B2

Reaction notes

Loading…